5
Total investments
1
Early stage
1
Mid stage
0
Late stage
9y
Years active
Portfolio
5 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Angel Investor
Jun 2022
Calibrate is on a mission to change the way the world treats weight. As the leading clinician-guided and value-based outcomes model in obesity treatment, Calibrate combines medication with transformative behavior change to improve overall metabolic health, driving cost-effective, long-term weight loss results while reducing the total cost of care for employers and payers.
Recognized by esteemed organizations, including the World Economic Forum’s Technology Pioneers, Fast Company’s World Changing Ideas, TIME’s Best Inventions, and the Employer Health Innovation Roundtable Traction Awards. Calibrate is backed by leading healthcare investors, including Madryn Asset Management, and Redesign Health.
Angel Investor
Jul 2021
Freedom and Dignity Restored. Make it to the bathroom in time with DFree, Australia first wearable device for managing urinary incontinence.
Incontinence is a major problem throughout Australian society. It affects 20% of the Australian population, over 70% of people living in nursing homes and is increasing steadily given our aging population and the increase of those living with disabilities with- in the community.
Aside from the personal difficulties that arise from incontinence, an enormous recurring cost burden is placed on the health care sector arising from related problems such as falls injuries as people rush to the bathroom, infections, skin problems and psychological trauma.
Up until now, the only remedy for sufferers of incontinence has been the use of diapers or invasive medical intervention.
Our product is a game changer. It removes the need for incontinence aids and gives sufferers back their dignity. DFree is a portable, wearable device that indicates when the user needs to go to the toilet. It is non-invasive and easy to use. DFree sends an alert to a users smartphone or tab- let to provide them with ample time to attend the toilet. It avoids the use of incontinence pads which can lead to incontinence dermatitis and urinary tract infections.
Angel Investor
Jul 2021
トリプル・ダブリュー・ジャパン株式会社では、“世界初”の排泄予知デバイス「DFree(ディーフリー)」を開発しています。
「DFree」は超音波センサーを内蔵した手のひらに収まるサイズの小型ウェアラブルデバイスで、下腹部に装着することで体内をモニタリングし、本体から無線通信によりクラウドへ情報を送り、独自のアルゴリズムによって得られた排泄予測情報をスマートフォン等の通信端末へお知らせします。
Angel Investor
Feb 2021
Meet RxDiet. Our mission is to use technology to empower members’ healthcare journeys by unlocking the full potential of food as medicine. Through our proprietary artificial intelligence and national grocery retail integrations, we provide delivery of medically-tailored groceries and clinical behavioral health interventions for patients...meeting patients where they are.
Experience · 10 entries
All (10)
Investments (5)
Founder (5)
2024
Co-Founder
Apr 2024
Taomics Inc. is a healthcare company that uses multi-omics data to empower people to live healthier lives. We believe everyone deserves access to the information and tools needed to control their health.
2022
Angel Investor
Jun 2022
Calibrate is on a mission to change the way the world treats weight. As the leading clinician-guided and value-based outcomes model in obesity treatment, Calibrate combines medication with transformative behavior change to improve overall metabolic health, driving cost-effective, long-term weight loss results while reducing the total cost of care for employers and payers.
Recognized by esteemed organizations, including the World Economic Forum’s Technology Pioneers, Fast Company’s World Changing Ideas, TIME’s Best Inventions, and the Employer Health Innovation Roundtable Traction Awards. Calibrate is backed by leading healthcare investors, including Madryn Asset Management, and Redesign Health.
2021
Founder Fellow
Sep 2021
Our mission is to help more people start better startups.
ODF is a program we created over four years ago to help those at the exploration stage of starting a company. So far, weve helped over 1000 companies get started and raise over $2 billion.
Starting a company is really exciting, but there are so many things you need to figure out in order to actually build one.
- "Who might I start my company with?"
- “What might we build?”
- “Who might our initial customers be?”
- “Should we raise funding soon, or should we try to bootstrap in the beginning?"
These and many more questions are what we refer to as the "missing pieces"—the things you need to figure out to know if starting a company is right for you and what company you should ultimately build.
With ODF, we bring together 80 to 100 people who are at the very same stage as you. Theyre all exceptionally talented, and theyre all trying to figure it out together.
Angel Investor
Jul 2021
Freedom and Dignity Restored. Make it to the bathroom in time with DFree, Australia first wearable device for managing urinary incontinence.
Incontinence is a major problem throughout Australian society. It affects 20% of the Australian population, over 70% of people living in nursing homes and is increasing steadily given our aging population and the increase of those living with disabilities with- in the community.
Aside from the personal difficulties that arise from incontinence, an enormous recurring cost burden is placed on the health care sector arising from related problems such as falls injuries as people rush to the bathroom, infections, skin problems and psychological trauma.
Up until now, the only remedy for sufferers of incontinence has been the use of diapers or invasive medical intervention.
Our product is a game changer. It removes the need for incontinence aids and gives sufferers back their dignity. DFree is a portable, wearable device that indicates when the user needs to go to the toilet. It is non-invasive and easy to use. DFree sends an alert to a users smartphone or tab- let to provide them with ample time to attend the toilet. It avoids the use of incontinence pads which can lead to incontinence dermatitis and urinary tract infections.
Angel Investor
Jul 2021
トリプル・ダブリュー・ジャパン株式会社では、“世界初”の排泄予知デバイス「DFree(ディーフリー)」を開発しています。
「DFree」は超音波センサーを内蔵した手のひらに収まるサイズの小型ウェアラブルデバイスで、下腹部に装着することで体内をモニタリングし、本体から無線通信によりクラウドへ情報を送り、独自のアルゴリズムによって得られた排泄予測情報をスマートフォン等の通信端末へお知らせします。
Show all 10 entries ↓
Investment activity
2017–2022 · 5 investments
Recent (last 2 years)Earlier
